These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 15966189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K, Chijiiwa K, Torato N, Kinoshita M, Tanaka M.
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
    Yamaguchi K, Chijiiwa K, Noshiro H, Torata N, Kinoshita M, Tanaka M.
    Hepatogastroenterology; 1999 Aug; 46(28):2575-81. PubMed ID: 10522044
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular genetics of malignant insulinoma.
    Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrook P, Gluckman JL, Pavelic ZP.
    Anticancer Res; 1996 Aug; 16(4A):1707-17. PubMed ID: 8712689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, Takayama T, Makuuchi M.
    Am J Gastroenterol; 1999 Aug 15; 94(8):2128-34. PubMed ID: 10445539
    [Abstract] [Full Text] [Related]

  • 17. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
    Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T.
    J Hepatobiliary Pancreat Surg; 2002 Aug 15; 9(3):312-21. PubMed ID: 12353142
    [Abstract] [Full Text] [Related]

  • 18. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H, Trümper L, Bürger B, Jacobs G, Kriener S, von Blohn G, Zeitz M, Pfreundschuh M.
    Dtsch Med Wochenschr; 1995 Jun 09; 120(23):821-5. PubMed ID: 7781522
    [Abstract] [Full Text] [Related]

  • 19. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
    Abbruzzese JL, Evans DB, Raijman I, Larry L, King T, Leach SD, Frazier ML.
    Anticancer Res; 1997 Jun 09; 17(2A):795-801. PubMed ID: 9137410
    [Abstract] [Full Text] [Related]

  • 20. Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation?
    Abbruzzese JL.
    Cancer J; 2000 Jun 09; 6(5):282-4. PubMed ID: 11079165
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.